Connor, Clark & Lunn Investment Management (CC&L)
BIOA

Connor, Clark & Lunn Investment Management (CC&L)’s BioAmber Inc. BIOA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,045,276
Closed -$5.36M – 987
2017
Q2 		$5.36M Buy
+2,045,276
New +$4.7M 0.04% 261

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BIOA Position: Q3 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 2,045,276 shares — an estimated $5.36M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BIOA in Q2 2017 and held it in 1 quarter. The position peaked at $5.36M in Q2 2017. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 2,045,276 BioAmber Inc. shares in Q3 2017, an estimated $5.36M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BioAmber Inc. in Q2 2017 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s BioAmber Inc. position peaked at $5.36M in Q2 2017.
  • 30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2017, filed 14 Nov 2017.